Welcome to BioRN Biotech Cluster Rhine-Neckar Delegation of the Limburgse Werkgevers Vereniging Christian Tidona Heidelberg, June 10, 2015
Welcome to BioRN Biotech Cluster Rhine-Neckar
Delegation of the Limburgse Werkgevers Vereniging
Christian Tidona Heidelberg, June 10, 2015
My Entrepreneurial Journey
1999: PhD Molecular Virology
2000: Multimetrix (Diagnostics)
2002: Cytonet (Cell Therapy)
2008: HI-STEM (Cancer Research)
2009: BioRN (Regional Development)
2013: BioMed X (Innovation Center)
2 www.bio.mx BioMed X Innovation Center
History of the BioRN Cluster
1984: Foundation of Heidelberg Technology Park
1996: Winner of BioRegio Competition 1997-2001: 35 Projects / €26.1m grant + 31,3m industry contribution Focus: Generation of startups
2008: Winner of Leading-Edge Cluster Competition 2009-2013: 44 Projects / €40m grant + €40m industry contribution Focus: Economic value creation
2015: Winner of Cluster Internalization Grant 2016-2019: €4m grant + €4m industry contribution Focus: Extension of Health Axis Europe, SME Launchpad
3
Cell-Based and Molecular Medicine 95 Biotech companies with R&D
3,800 Jobs
3 Global Players 16,000 Jobs
6 Universities and Research Institutions 15,000 Jobs
BioRN Cluster
Partners
4
Large Biotech and Pharma Companies
Biotech SMEs
Academic Education and Research
BioRN Cluster
Scientific Excellence
5
University of Heidelberg
Highest ranked German university (#29) in the top 100 of the QS World University Rankings 2013 in life sciences
Heidelberg University Hospital
Highest ranked university clinic in the German CHE Research Ranking 2009 (11,700 employees, 1,900 beds, annual budget: 1.1 billion €)
German Cancer Research Center (DKFZ)
Largest biomedical research center in Germany, international leader in cancer research (3,000 employees)
European Molecular Biology Laboratory (EMBL)
One of the world's top research institutions for molecular biology and bioinformatics (1,400 employees)
BioRN Cluster
Campus Infrastructure
6
Heidelberg Life Science Campus Neuenheimer Feld • 140 hectares • Technology Park: 50,000 sqm lab
and office space for companies
New Life Science Campus Bahnstadt •20 hectares •Sky Labs: 20,000 sqm lab and office space
7
44 Projects, 43 Partners (32 Private, 11 Public) €40M Grant (+ €40M Industry Funding) 38 Patent Applications 34 Journal Publications 13 SME Financing Rounds (€118M) 4 Licensing Deals (Upfront >€60M, MS >€500M) 2 M&A Deals (€266M)
BioRN Leading-Edge Cluster Funding Summary of Results (2009-2013)
BioRN Cluster Management
EU Gold Label
8
Source: http://whatmatters.mckinseydigital.com/flash/innovation_clusters/
Silicon Valley
Innovation Clusters with Critical Mass
USA
EU Innovation Clusters with Critical Mass
Source: http://whatmatters.mckinseydigital.com/flash/innovation_clusters/
Ci3 – Cluster for Individualized Immune Intervention
BioRN – Cluster for Cell-Based and Molecular Medicine
Rhine-Main-Neckar Supercluster
+ about 150 SMEs with R&D
Mainz
Heidelberg
Fostering Health Innovation Across Europe
Health Axis Europe
12
13
Strong Health Technology Clusters in Europe Matching Profiles
Cambridge Leuven Heidelberg internationally outstanding universities with
excellent health sciences and a strong tradition in top education and research
substantial health industry base driven by strong key individuals
that are personally committed to foster economic growth and entrepreneurship
special expertise in complementary health technology areas regenerative medicine and
eHealth
medical electronics and nanotechnology
personalized medicine and
cancer research
Health Axis Europe Constitution Signed
14
Leuven, June 8th, 2011 Maastricht will join June 10th, 2015
© K.U.Leuven - Rob Stevens
15
Health Axis Europe Objectives & Projects
Joining health innovation resources in order to increase international competitiveness HAE R&D Community: Facilitate and coordinate EU-
funded collaborative R&D projects
HAE Academy: Facilitate cross-border talent education and exchange (students, scientists, and entrepreneurs)
HAE Accelerator: Facilitate cross-border startup incubation, VC investment and syndication
http://www.health-axis.eu
16
community.health-axis.eu
17
KIC InnoLife Consortium UK CLC
Benelux CLC
French CLC
German CLC
Spanish CLC
Scandinavian CLC
Södertörn Councils
18
19
Oncology Program
Comprehensive Cancer Centers • Cancer Center Karolinska • Cambridge Cancer Centre • The Netherlands Cancer Institute
(NKI) • German Cancer Research Centre
(DKFZ) / NCT • Gustave Roussy Institute • Vall d’Hebron Institute of Oncology
accelerator.health-axis.eu
20
21
HAE Accelerator Stages & Modules
Stage 1: HAE Business Plan Competition BPC in each HAE partner region
Heidelberg Competition
Leuven Competition
Cambridge Competition
March – June 2013
Stage 2: HAE Summer Camp 4 days, Heidelberg
Training, Coaching, Mentoring
21 – 24 September 2013
top teams
25 Sept. 2013
Stage 3: HAE Expo 1 day, Heidelberg
Presentations, Awards
Ceremony, VC Partnering
HAE Accelerator Finalists
Therapeutics Diagnostics
Health IT
23
Health Axis Europe Future Perspective
HAE SME Launchpad Annual HAE Accelerator: finals rotating among
member clusters
Annual HAE Innovation Boot Camps: in each member cluster
Annual HAE Innovation Conference: rotating among member clusters
HAE SME Community: web-based platform for health SMEs across Europe
New Innovation Model: Global crowdsourcing and local incubation of the brightest ideas and talents
24 www.bio.mx BioMed X Innovation Center
New Innovation Model @ BioMed X
Global crowdsourcing: world-wide call for application Boot camp: selection of the best of
the best ideas and talents Local incubation: 2-4 year
fellowships at BioMed X Innovation Center in Heidelberg
25
Betz & Tidona (2015) Nature Biotechnology 33(1), 20-21
BioMed X
Call for Application (Example: Merck)
BioMed X 26
519 Applications from 59 countries (29x) India: 109 Male: 319 Group Leaders: 110 Germany: 100 Female: 200 Postdocs: 291 USA: 66 Postgraduates: 118 UK: 28 Spain: 28 Italy: 21 China: 19
32 Candidates selected from 10 countries (6%) Germany: 10 Male: 19 Group Leaders: 9 USA: 6 Female: 13 Postdocs: 21 UK: 4 Postgraduates: 2
BioMed X 27
BioMed X Boot Camp
Pharma Sponsors (BioMed X Heidelberg)
BioMed X 28
Metabolism and Signaling in Cancer
Selective Kinase Inhibitors
Immunosuppressive Microenvironment of Tumors
Epigenetics and Chronic Obstructive
Pulmonary Disease
Nanomaterial-Based Biosensors for Near-Patient Testing
Tau-Mediated Neurodegeneration in Alzheimer’s Disease
“Creativity is intelligence having fun.”
Albert Einstein
BioMed X 29
Deutscher Spitzencluster 2008, unterstützt durch:
30